Health
Phase 1 trial results of gorilla adenovirus vaccine for COVID-19 – News-Medical.Net
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained…
A recent study published on the preprint server bioRxiv* in October 2020 reports the development of a novel vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help speed up vaccine development.
Low Seroprevalence for Simian Adenoviruses
Simian adenoviruses are isolated from non-human primates like the chimpanzee and gorilla and do not infect humans. Their prevalence is, therefore, low or non-existent among humans. They have been used to…
-
Noosa News23 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Business23 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News19 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoPappa Flock is Now Open in Westfield Chermside